Hibernating myocardium
Hibernating myocardium is a state in which segments of the myocardium exhibit reduced contractile function at rest, but retain viability and can recover function if the coronary blood flow is improved. This condition is often associated with coronary artery disease and can lead to heart failure if not properly managed.
Causes[edit]
The primary cause of hibernating myocardium is chronic ischemia, a condition characterized by reduced blood flow to the heart. This is most commonly due to coronary artery disease, where the coronary arteries become narrowed or blocked by atherosclerotic plaques. Other potential causes include cardiomyopathy, heart valve disease, and congenital heart defects.
Symptoms[edit]
The symptoms of hibernating myocardium can vary widely, depending on the extent and location of the affected myocardium. Common symptoms include chest pain, shortness of breath, fatigue, and palpitations. In severe cases, hibernating myocardium can lead to heart failure, with symptoms such as edema, weight gain, and shortness of breath.
Diagnosis[edit]
The diagnosis of hibernating myocardium is typically made based on a combination of medical history, physical examination, and diagnostic tests. These tests may include electrocardiogram, echocardiogram, cardiac MRI, and nuclear stress test. In some cases, coronary angiography may be performed to directly visualize the coronary arteries.
Treatment[edit]
The treatment of hibernating myocardium is primarily aimed at improving coronary blood flow and reducing the workload of the heart. This may involve medications such as beta blockers, calcium channel blockers, and nitrates. In some cases, revascularization procedures such as coronary artery bypass grafting or percutaneous coronary intervention may be recommended.
Prognosis[edit]
The prognosis of hibernating myocardium depends on a variety of factors, including the extent and location of the affected myocardium, the underlying cause of the ischemia, and the patient's overall health. With appropriate treatment, many patients can experience significant improvement in symptoms and quality of life.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
